The hybrid 4k exhibited maximum inhibition of α-glucosidase enzyme with favorable binding interactions, suggesting this framework is a potential lead motif for future antidiabetic drug discovery.
Abstract
Aim
The present research work aims to synthesize and explore the in vitro α-glucosidase inhibition potentials of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazoles to counter diabetes mellitus.
Materials And Methods
A series of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazole hybrids (4a-4l) was synthesized and characterized using various spectral techniques viz FTIR, NMR, and HRMS. The hybrids were further assayed for in vitro α-glucosidase inhibition. The findings were further justified by in silico studies.
Results
The findings of in vitro study suggested triazole hybrid 4k as the most potent α-glucosidase inhibitor (IC50 = 1.35 µM) compared to acarbose (IC50 = 13.5 µM). Molecular docking (MD) investigations of ligand-protein complex revealed favorable binding interactions.
Conclusions
The hybrid 4k exhibited maximum inhibition of α-glucosidase enzyme with favorable binding interactions, suggesting this framework is a potential lead motif for future antidiabetic drug discovery.
A series of 5-(substituted)-1,3-thiazolidine-2,4-diones (C1-C6) were designed, synthesized and characterized by FT-IR, 1H NMR, 13C NMR and mass spectral analyses, revealing the positive contribution of the 1,3-thiazolidine-2,4-dione moiety and the phenyl ring substituents at the 5-position of the 1,
L. H. Tan, Lai-Chun Wong, V. Avupati· Asian Journal of Chemistry· 0 citations
In the present study, new multifunctional imidazoles which contains the synthesis and biological activity experiments have been reported as α-glucosidase inhibitors. The procedure of imidazole-hydrazone derivative compounds (ISA1-5) relies on the condensation reaction of 5-Cl isatin and 2-benzylidenehydrazinecarboximid...
Semiha Köprü· Bitlis Eren Üniversitesi Fen...· 0 citations
Quinoline-Thiazolidinedione-2,4-Dione demonstrated strong antihyperglycemic and antihypertriglyceridemic activities in zebrafish models, supported by in silico validation.
ElShimaa Ahmed Mohamed Abousaada, A. Galal-Khallaf, K. Mohammed-Geba et al.· Pharmaceuticals· 0 citations
Kinetic enzyme assays revealed that compound 9f acts as a competitive inhibitor of α-glucosidase, competing with the natural substrate for binding to the active site, with a Ki value of 100 nM, and pharmacokinetic predictions showed that compound 9f exhibits a bioavailability radar and drug-likeness profile similar to...
Shahab Kermaninia, M. Sayahi, Mohammad Halimi et al.· RSC Advances· 0 citations
Diabetes mellitus is a chronic metabolic disorder associated with persistent hyperglycemia and the development of numerous secondary complications. In the present study, a series of 4-aminochalcone derivatives (1N–10N) were synthesized and evaluated as potential dual inhibitors of α-glucosidase and aldose reductase usi...
E. Mughal, Nafeesa Naeem, Songül Bayrak et al.· RSC Advances· 0 citations